Daratumumab

Item number	Size	Manual	Delivery time	Price
TGM-T9918-1mg	1 mg	-	7 - 10 business days*	144.00€
TGM-T9918-5mg	5 mg	-	7 - 10 business days*	502.00€
TGM-T9918-10mg	10 mg	-	7 - 10 business days*	633.00€
TGM-T9918-25mg	25 mg	-	7 - 10 business days*	967.00€
TGM-T9918-50mg	50 mg	-	7 - 10 business days*	1,353.00€
TGM-T9918-100mg	100 mg	-	7 - 10 business days*	1,825.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein... more

Close menu

Product information "Daratumumab"

Description: Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein that is overexpressed on multiple myeloma MM) cells. Target: ADC Antibody, Others. References: Michel de Weers, et al. Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors. J Immunol. 2011 Feb 1,186(3):1840-8.

Supplier:	TargetMol
Supplier-Nr:	T9918

Properties

Conjugate:	No
MW:	148 kD

Database Information

KEGG ID :	K01242 \| Matching products
UniProt ID :	P28907 \| Matching products
Gene ID :	GeneID 952 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Daratumumab"

Write a review